loading page

Relationship of the Lymphocyte-to-C-reactive Protein Ratio with Overactive Bladder Risk: A Cross-Sectional Assessment Involving United States Adults
  • Junjie Ni,
  • liu xin,
  • Yibo Zhou
Junjie Ni
jin hua shi zhong xin yi yuan
Author Profile
liu xin
The 903rd Hospital of the Joint Logistics Support Force of the People's Liberation Army of China

Corresponding Author:liuxin9192@126.com

Author Profile
Yibo Zhou
jin hua shi zhong xin yi yuan
Author Profile

Abstract

Aims: The primary objective was an evaluation of the correlation between the lymphocyte-to-C-reactive protein ratio (LCR) and the prevalence of overactive bladder (OAB) within the adult United States population. Methods: Data was collected from the National Health and Nutrition Examination Survey (2005‒2010), and involved a non-pregnant cohort aged ≥20 years of age, with available LCR index and OAB information. We employed weighted univariate and multivariate logistic regression to assess the link between LCR and OAB risk. Subgroup, examinations of interaction, and restricted cubic spline analyses were also performed. Results: In all, 13723 subjects were recruited for analysis. Among them, 14.99% exhibited OAB and the mean LCR value was 2.61±0.07. The OAB risk decreased with higher quartiles of LCR. In model 2, subjects in the highest LCR quartiles showed 48% (OR: 0.52, 95%CI: 0.38–0.71, P < 0.001) reductions in the OAB risk, relative to those in the lowest LCR quartiles. These negative associations were found to be independent of various factors, shown in the subgroup analyses and interaction tests. Additionally, based on the restricted cubic spline analyses, there was a negative, non-linear relationship between LCR and OAB risk.
27 Jul 2024Submitted to Immunity, Inflammation and Disease
01 Aug 2024Submission Checks Completed
01 Aug 2024Assigned to Editor
24 Aug 2024Reviewer(s) Assigned
19 Nov 2024Review(s) Completed, Editorial Evaluation Pending
20 Nov 2024Editorial Decision: Revise Major
08 Dec 20241st Revision Received
11 Dec 2024Submission Checks Completed
11 Dec 2024Assigned to Editor
11 Dec 2024Review(s) Completed, Editorial Evaluation Pending
12 Dec 2024Reviewer(s) Assigned